Esophagogastric Junction Adenocarcinoma Active Not Recruiting Phase 1 / 2 Trials for Oteracil (DB03209)

Also known as: Adenocarcinoma, Esophagogastric Junction

IndicationStatusPhase
DBCOND0042000 (Esophagogastric Junction Adenocarcinoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02564367Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric JunctionTreatment